Skip to main content

ARS Pharmaceuticals, Inc.

SPRY
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001671858

No open-market purchases or sales by ARS Pharmaceuticals, Inc. insiders were filed in the last 90 days; 208 institutions reported holding it in 13F filings for Q2 2026, worth $726.0M in total; Third Point is the only superinvestor holding it.

Open-market trades, last 90 days

Open-market purchases (P) and sales (S) by ARS Pharmaceuticals, Inc. insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.

Open-market buys
0 filings
Open-market sells
0 filings
Insiders trading
0
Net value
$0
Purchases minus sales

Insider roster

Directors, officers and 10% owners who have filed a Form 4 for ARS Pharmaceuticals, Inc., current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.

Insider roster for ARS Pharmaceuticals, Inc.
NameTitleLast reported holdingLast filingFilings, past year
Smith Margaret EkinsChief Commercial Officer–Sep 2, 20261
Casale DonnPresident–Jul 2, 20261
RA Capital Healthcare Fund LPDirector, 10% Owner9,958,073IndirectJun 26, 20261
Ra Capital Management, L.P.Director, 10% Owner9,958,073IndirectJun 26, 20261
Kolchinsky PeterDirector, 10% Owner9,958,073IndirectJun 26, 20261
Shah Rajeev M.Director, 10% Owner9,958,073IndirectJun 26, 20261
RA Capital Nexus Fund II, L.P.Director9,958,073IndirectJun 26, 20261
Schneider Phillip MDirector–Jun 26, 20261
Saunders Brent LDirector0Jun 26, 20261
Thompson Peter A.Director0IndirectJun 26, 20261
Shawver LauraDirector210,346Jun 26, 20261
Islam SaqibDirector–Jun 26, 20261
Shah PratikDirector4,474,554IndirectJun 26, 20262
Dadoo RajeevDirector3,009,677IndirectJun 26, 20261
Kelly MichaelDirector83,225IndirectJun 26, 20261
Fitzpatrick Alexander AChief Legal Officer90,910Jun 12, 20262
Karas EricChief Commercial Officer12,176Jun 12, 20262
Lowenthal Richard EPRESIDENT AND CEO1,196,494IndirectJan 5, 20261
Dorsey BrianChief Operating Officer10,789Jan 5, 20262
Scott Kathleen D.Chief Financial Officer10,042Jan 5, 20261
Chakma JustinChief Business Officer0Jan 5, 20262
Tanimoto SarinaCHIEF MEDICAL OFFICER1,247,447IndirectJan 5, 20261
Deerfield Management Company, L.P.10% Owner4,887,254IndirectJul 1, 20250
Flynn James E10% Owner4,887,254IndirectJul 1, 20250
Deerfield Private Design Fund III, L.P.10% Owner4,887,254IndirectJul 1, 20250
Deerfield Mgmt III, L.P.10% Owner4,887,254IndirectJul 1, 20250
Deerfield Private Design Fund IV, L.P.10% Owner4,887,254IndirectJul 1, 20250
Deerfield Mgmt IV, L.P.10% Owner4,887,254IndirectJul 1, 20250
OrbiMed Advisors LLCDirector0IndirectAug 28, 20240
OrbiMed Capital LLCDirector0IndirectAug 28, 20240
OrbiMed Capital GP VI LLCDirector0IndirectAug 28, 20240
Pratik Shah Living Trust dated June 15, 201110% Owner7,490,404IndirectJun 7, 20240
Root Jonathan DDirector2,364IndirectJun 13, 20220
Capps Vickie LDirector–Jun 13, 20220
Hershberg RobertDirector–Jun 13, 20220
Powell Andrew Kenneth WilliamDirector–Jun 13, 20220
Koehler MariaDirector–Jun 13, 20220
Hawkinson RussSr. Vice President of Finance37,251May 4, 20220
Piazza JonathanChief Financial Officer69,225May 4, 20220
Hunder NaomiChief Medical Officer54,427May 4, 20220
Odegard ValeriePresident and CSO61,639May 4, 20220

Insider trades

Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Aug 21, 2024 (view filing)Aug 192 daysKaras EricChief Commercial OfficerSSale−10.0K$14.00−$140.0K−63.7%5.69K after10b5-1
Aug 21, 2024 (view filing)Aug 201 dayScott Kathleen D.Chief Financial OfficerSSale−12.5K$16.00−$200.0K−48.6%13.2K after10b5-1
Aug 21, 2024 (view filing)Aug 201 dayTanimoto SarinaCHIEF MEDICAL OFFICERSSale−100.0K$15.03−$1.50M−6.3%1.50M after6 lots10b5-1Duplicate filing
Aug 21, 2024 (view filing)Aug 201 dayLowenthal Richard EPRESIDENT AND CEOSSale−100.0K$15.03−$1.50M−6.3%1.50M after6 lots10b5-1
Aug 15, 2024 (view filing)Aug 132 daysDorsey BrianChief Operating OfficerSSale−30.0K$13.00−$390.0K−83.3%6.02K after10b5-1
Aug 15, 2024 (view filing)Aug 132 daysTanimoto SarinaCHIEF MEDICAL OFFICERSSale−100.0K$12.48−$1.25M−6.1%1.55M after4 lots10b5-1Duplicate filing
Aug 15, 2024 (view filing)Aug 132 daysLowenthal Richard EPRESIDENT AND CEOSSale−100.0K$12.48−$1.25M−6.1%1.55M after4 lots10b5-1
Jul 18, 2024 (view filing)Jul 162 daysLowenthal Richard EPRESIDENT AND CEOSSale−100.0K$11.40−$1.14M−5.9%1.60M after2 lots10b5-1Duplicate filing
Jul 18, 2024 (view filing)Jul 162 daysTanimoto SarinaCHIEF MEDICAL OFFICERSSale−100.0K$11.40−$1.14M−5.9%1.60M after2 lots10b5-1
Jul 11, 2024 (view filing)Jul 92 daysTanimoto SarinaCHIEF MEDICAL OFFICERSSale−100.0K$9.62−$962.0K−5.7%1.65M after2 lots10b5-1Duplicate filing
Jul 11, 2024 (view filing)Jul 92 daysLowenthal Richard EPRESIDENT AND CEOSSale−100.0K$9.62−$962.0K−5.7%1.65M after2 lots10b5-1
Jun 13, 2024 (view filing)Jun 11-122 daysTanimoto SarinaCHIEF MEDICAL OFFICERSSale−100.0K$9.14−$913.9K−5.6%1.70M after4 lots10b5-1Duplicate filing
Jun 13, 2024 (view filing)Jun 11-122 daysLowenthal Richard EPRESIDENT AND CEOSSale−100.0K$9.14−$913.9K−5.6%1.70M after4 lots10b5-1
May 16, 2024 (view filing)May 14-162 daysTanimoto SarinaCHIEF MEDICAL OFFICERSSale−100.0K$9.06−$905.6K−5.4%1.75M after6 lots10b5-1Duplicate filing
May 16, 2024 (view filing)May 14-162 daysLowenthal Richard EPRESIDENT AND CEOSSale−100.0K$9.06−$905.6K−5.4%1.75M after6 lots10b5-1
May 9, 2024 (view filing)May 72 daysTanimoto SarinaCHIEF MEDICAL OFFICERSSale−100.0K$9.34−$934.0K−5.3%1.80M after2 lots10b5-1Duplicate filing
May 9, 2024 (view filing)May 72 daysLowenthal Richard EPRESIDENT AND CEOSSale−100.0K$9.34−$934.0K−5.3%1.80M after2 lots10b5-1
Apr 17, 2024 (view filing)Apr 161 dayTanimoto SarinaCHIEF MEDICAL OFFICERSSale−100.0K$9.28−$928.0K−5.1%1.85M after2 lots10b5-1Duplicate filing
Apr 17, 2024 (view filing)Apr 161 dayLowenthal Richard EPRESIDENT AND CEOSSale−100.0K$9.28−$928.0K−5.1%1.85M after2 lots10b5-1
Apr 10, 2024 (view filing)Apr 91 dayTanimoto SarinaCHIEF MEDICAL OFFICERSSale−100.0K$9.28−$928.0K−5.0%1.90M after2 lots10b5-1Duplicate filing
Apr 10, 2024 (view filing)Apr 91 dayLowenthal Richard EPRESIDENT AND CEOSSale−100.0K$9.28−$928.0K−5.0%1.90M after2 lots10b5-1
Mar 27, 2024 (view filing)7:37 PM ETMar 25-272 daysRA Capital Healthcare Fund LP and 4 othersDirectorPPurchase+1.40M$9.48+$13.3M+16.4%9.96M after3 lots
Mar 26, 2024 (view filing)Mar 22-254 daysLowenthal Richard EPRESIDENT AND CEOSSale−97.6K$9.12−$890.0K−4.8%1.95M after4 lots10b5-1Duplicate filing
Mar 26, 2024 (view filing)Mar 22-254 daysTanimoto SarinaCHIEF MEDICAL OFFICERSSale−97.6K$9.12−$890.0K−4.8%1.95M after4 lots10b5-1
Mar 21, 2024 (view filing)Mar 19-212 daysLowenthal Richard EPRESIDENT AND CEOSSale−2.39K$9.03−$21.6K−0.1%2.00M after4 lots10b5-1Duplicate filing
Mar 21, 2024 (view filing)Mar 19-212 daysTanimoto SarinaCHIEF MEDICAL OFFICERSSale−2.39K$9.03−$21.6K−0.1%2.00M after4 lots10b5-1
Mar 15, 2024 (view filing)Mar 13-152 daysLowenthal Richard EPRESIDENT AND CEOSSale−100.0K$9.14−$913.5K−4.8%2.00M after6 lots10b5-1Duplicate filing
Mar 15, 2024 (view filing)Mar 13-152 daysTanimoto SarinaCHIEF MEDICAL OFFICERSSale−100.0K$9.14−$913.5K−4.8%2.00M after6 lots10b5-1
Mar 1, 2024 (view filing)Feb 291 dayTanimoto SarinaCHIEF MEDICAL OFFICERSSale−3.78K$9.01−$34.1K−0.2%1.75M after3 lots10b5-1Duplicate filing
Mar 1, 2024 (view filing)Feb 291 dayLowenthal Richard EPRESIDENT AND CEOSSale−3.78K$9.01−$34.1K−0.2%1.75M after3 lots10b5-1
Feb 28, 2024 (view filing)Feb 26-282 daysTanimoto SarinaCHIEF MEDICAL OFFICERSSale−99.5K$9.02−$897.3K−5.4%1.75M after6 lots10b5-1Duplicate filing
Feb 28, 2024 (view filing)Feb 26-282 daysLowenthal Richard EPRESIDENT AND CEOSSale−99.5K$9.02−$897.3K−5.4%1.75M after6 lots10b5-1
Oct 2, 2023 (view filing)Sep 28-294 daysFitzpatrick Alexander AChief Legal OfficerPPurchase+86.3K$3.71+$319.7K+2,905.3%89.2K after2 lots
Sep 25, 2023 (view filing)4:30 PM ETSep 214 daysRA Capital Healthcare Fund LP and 4 othersDirectorPPurchase+2.70M$3.03+$8.18M+46.1%8.56M after2 lots
Sep 5, 2023 (view filing)Sep 14 daysShawver LauraDirectorSSale−100.0K$7.71−$771.0K−32.2%210.3K after10b5-1
Aug 31, 2023 (view filing)5:26 PM ETAug 292 daysRA Capital Healthcare Fund LP and 4 othersDirectorPPurchase+3.75M$6.20+$23.3M+178.0%5.86M after
Aug 31, 2023 (view filing)5:26 PM ETAug 292 daysOrbiMed Advisors LLC and 2 othersDirectorPPurchase+500.0K$6.20+$3.10M+6.6%8.02M afterDuplicate filing
Aug 31, 2023 (view filing)Aug 292 daysThompson Peter A.DirectorPPurchase+500.0K$6.20+$3.10M+6.6%8.02M after
Aug 7, 2023 (view filing)Aug 3-44 daysShawver LauraDirectorSSale−45.0K$7.03−$316.4K−17.6%210.3K after2 lots10b5-1
Aug 3, 2023 (view filing)Aug 1-22 daysShawver LauraDirectorSSale−55.0K$7.12−$391.8K−20.7%210.3K after2 lots10b5-1
Jul 7, 2023 (view filing)Jul 7Same dayShawver LauraDirectorSSale−8.86K$6.36−$56.3K−4.0%210.3K after
Jul 6, 2023 (view filing)Jul 3-63 daysShawver LauraDirectorSSale−91.1K$6.48−$590.4K−30.2%210.3K after3 lots
Jun 2, 2023 (view filing)Jun 1-21 dayShawver LauraDirectorSSale−100.0K$6.84−$684.0K−32.2%210.3K after2 lots10b5-1
May 10, 2023 (view filing)Nov 9, 2022-May 9, 2023182 daysLateShawver LauraDirectorSSale−143.9K$5.42−$780.6K−40.6%210.3K after3 lots10b5-1
Dec 1, 2022 (view filing)Nov 292 daysScott Kathleen D.Chief Financial OfficerPPurchase+8.25K$6.24+$51.5KNew position8.25K after
Mar 18, 2022 (view filing)Mar 3-Nov 15, 2021380 daysLateRoot Jonathan DDirectorPPurchase+2.36K$15.25+$36.0KNew position2.36K after2 lots
Feb 24, 2022 (view filing)Dec 8, 2020443 daysHawkinson RussSr. Vice President of FinancePPurchase+200$21.00+$4.20KNew position200 afterAmended